Clinical Case Database / Category: Patient Management

Age related macular degeneration: focus on wet macular degeneration

Publication details

S Paneerselvam, N Narendran, M Tahir, Yit Yang
Foundation Years Journal, volume 6, issue 10, p.12 (123Doc Education, London, November 2012)


Age related macular degeneration (ARMD) is a very common cause of visual impairment in the elderly. This case report describes a very typical scenario and highlights important aspects in diagnosis and management of macular disease which junior doctors in training should find useful.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Foundation Years Clinical Cases Database£29.006 months
Add to cart
Foundation Years Clinical Cases Database£39.0012 months
Add to cart


S Paneerselvam

Eye Infirmary
Royal Wolverhampton Hospitals NHS Trust
New Cross, Wolverhampton, WV10 0QP

N Narendran

Eye Infirmary
Royal Wolverhampton Hospitals NHS Trust
New Cross, Wolverhampton, WV10 0QP

M Tahir

Eye Infirmary
Royal Wolverhampton Hospitals NHS Trust
New Cross, Wolverhampton, WV10 0QP

Yit Yang

Eye Infirmary
Royal Wolverhampton Hospitals NHS Trust
New Cross, Wolverhampton, WV10 0QP


1. Owen C G et al. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?. Br J Ophthalmol. 2003 March; 87(3): 312–317.
2. Nowak J Z. Age-related macular degeneration- pathogenesis and therapy. Pharmacological Reports 2006;58:353-363.
3. Moutray T , Chakravarthy U. Age-related macular degeneration: Current treatment and future options. Ther Adv Chronic Dis.2011;2(5):325-331..
4. Virgili G, Do D V, Bressler N M, Menchini U. New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence. Acta Ophthalmol. 2007;85: 6-20
5. Shona O, Gupta B, Vemala R, Sivaprasad S. Visual acuity outcomes in ranibizumab-treated neovascular age-related macular degeneration; stratified by baseline vision. Clin Experiment Ophthalmol. 2011 Jan;39(1):5-8.
6. Brown D, Kaiser P, Michels M, Soubrane, G, Heier, J, Kim R. et al. for the ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006; 355: 1432-44.
7.Rosenfeld PJ, Brown DM, Heier JS, et al., Ranibizumab for neovascular age related macular degeneration (2 year results from the MARINA study), N Engl J Med, 2006;355:1419–31.
8. The CATT Research Group. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med 2011; 364:1897-19082.
9. Rovner B, Casten R. Activity loss and depression in age-related macular degeneration. Am J Geriatr Psychiatry 2002;10:305-310.
10. Brody L, Gamst C, Williams A et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001 Oct;108(10):1893-900.


Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts ( The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.